Home Fetal hyaloid artery in first trimester of pregnancy: slowflowHD study
Article Open Access

Fetal hyaloid artery in first trimester of pregnancy: slowflowHD study

  • Toshiyuki Hata EMAIL logo , Aya Koyanagi , Riko Takayoshi , Yasunari Miyagi and Takahito Miyake
Published/Copyright: October 9, 2024

Abstract

Objectives

To detect fetal hyaloid artery (FHA) blood flow using SlowflowHD in the first trimester.

Methods

During the 8-month period from February to September 2023, one-hundred and eighty-three trans-abdominal scans were performed for first-trimester screening in singleton pregnancies at 11–13 + 6 weeks of gestation. One-hundred and fifty-two cases were excluded from the study due to inappropriate fetal positions, excessive fetal movements, and excessive distances between the fetus and probe; thus, thirty-one fetuses (20.4 %) were examined, comprising 19 uni- and 12 bilateral orbits. One fetus with trisomy 21 was also evaluated at 12 weeks and 1 day. FHA was classified into two types based on the starting point angle (Straight, straightly diverged from ophthalmic artery; and Curved, crookedly diverged from ophthalmic artery) using SlowflowHD.

Results

In 19 uni- and 12 bilateral orbits in 31 fetuses, FHA could be identified in all orbits. In one orbit at 13 weeks and 5 days, blood flow on the string FHA could be detected. The vasa hyaloidea propria was noted in 3 orbits, and the posterior vascular capsule was depicted in 7 orbits. The incidence of Straight-type FHA increased with advancing gestation (p<0.0001). In a fetus with Trisomy 21, Straight-type FHA was noted in the left orbit, whereas FHA could not be identified in the right orbit.

Conclusions

This is the first report on the detection of FHA in the first trimester of pregnancy. SlowflowHD may be a useful diagnostic modality to evaluate human vascular development, such as FHA in utero.

Introduction

The fetal hyaloid artery (FHA) was reportedly detectable in 90 % of fetuses by the 14th week of gestation using transvaginal two-dimensional sonography [1]. FHA was detected in all cases at 14–18 weeks of gestation, and blood flow within FHA could be noted using conventional power Doppler until the 16th week of gestation [2]. Blood flow in FHA was evident in 83.5 % using SlowflowHD at 18–21 + 6 weeks of gestation [3]. However, there has been no study to assess blood flow in FHA in the first trimester of pregnancy.

SlowflowHD can detect fetal peripheral vessels with low-velocity blood flow [4, 5]. In this study, we attempted to detect FHA blood flow using SlowflowHD in the first trimester of pregnancy.

Materials and methods

During the 8-month period from February to September 2023, one-hundred and eighty-three trans-abdominal scans were performed for first-trimester screening in singleton pregnancies at 11–13+6 weeks of gestation. Crown-rump length (CRL) measurement at 8–10 + 6 weeks of gestation was conducted to confirm the fetal age [6]. SlowflowHD scans for FHA evaluations were conducted with Voluson E10 BT20 (GE Healthcare, Zipf, Austria) with a transabdominal transducer (GE C2-9-D, 3–9 MHz) or Voluson Expert22 BT22 (GE Healthcare, Zipf, Austria) with a transabdominal transducer (GE RM7C, 2–8 MHz). One-hundred and fifty-two cases were excluded from the study due to inappropriate fetal positions, excessive fetal movements, and excessive distances between the fetus and probe; thus, thirty-one healthy fetuses (20.4 %) were examined, comprising 19 uni- and 12 bilateral orbits. One fetus with trisomy 21 was also evaluated at 12 weeks and 1 day. The study was conducted following approval by the Ethics Committee of Miyake Clinic, Okayama, Japan. All participants provided written informed consent after a full explanation of the aims of the study.

All SlowflowHD examinations were carried out by one experienced sonographer (A.K.). The pulse repetition frequency (PRF) was set at 0.39–0.77 kHz and the wall motion filter to ‘low1’. The Thermal Index (TI) was set at 0.5 to 1.0, and Mechanical Index (MI) ranged from 0.6 to 1.0. The total examination time was within 2 min. The number of data acquisitions was 1–10.

FHA was visualized and evaluated by two examiners (T.H. and A.K.), with complete agreement between them (Figures 1, 2, and 3). FHA was classified into two types based on the starting point angle (Straight, straightly diverged from ophthalmic artery; and Curved, crookedly diverged from ophthalmic artery) using SlowflowHD (Figure 4). Cohen’s kappa coefficients for FHA-type classification for intra-observer (A.K.) and inter-observer agreements were 0.903 (almost perfect agreement) and 0.763 (substantial agreement), respectively [7].

Figure 1: 
Fetal hyaloid artery (HA) detected by slowflowHD at 11 weeks of gestation. OA, ophthalmic artery.
Figure 1:

Fetal hyaloid artery (HA) detected by slowflowHD at 11 weeks of gestation. OA, ophthalmic artery.

Figure 2: 
Fetal hyaloid artery (HA) detected by slowflowHD at 12 weeks and 2 days of gestation. L, lens; MCA, middle cerebral artery; OA, ophthalmic artery.
Figure 2:

Fetal hyaloid artery (HA) detected by slowflowHD at 12 weeks and 2 days of gestation. L, lens; MCA, middle cerebral artery; OA, ophthalmic artery.

Figure 3: 
Fetal hyaloid artery (HA) detected by slowflowHD at 13 weeks and 4 days of gestation. BRA, branch retinal artery; CRA, central retinal artery; L, lens; MCA, middle cerebral artery; OA, ophthalmic artery; PVC, posterior vascular capsule; VHP, vasa hyaloidea propria.
Figure 3:

Fetal hyaloid artery (HA) detected by slowflowHD at 13 weeks and 4 days of gestation. BRA, branch retinal artery; CRA, central retinal artery; L, lens; MCA, middle cerebral artery; OA, ophthalmic artery; PVC, posterior vascular capsule; VHP, vasa hyaloidea propria.

Figure 4: 
Starting point angle of fetal hyaloid artery (HA). OA, ophthalmic artery.
Figure 4:

Starting point angle of fetal hyaloid artery (HA). OA, ophthalmic artery.

FHA types among gestational ages were analyzed with the Cochran Armitage Linear Trend test, and each FHA type among gestational ages was analyzed with ANOVA. All analyses were performed with Mathematica 13.0.0.0 (Wolfram Research, Champaign, IL, USA). A p-value <0.05 was considered significant.

Results

In 19 uni- and 12 bilateral orbits in 31 fetuses, FHA could be identified in all orbits (Figures 1, 2, and 3 and Table 1). In one orbit at 13 weeks and 5 days, blood flow of the string FHA could be detected (Figure 5). The vasa hyaloidea propria was noted in 3 orbits, and the posterior vascular capsule was depicted in 7 orbits (Figure 3 and Table 1). The incidence of Straight-type FHA increased with advancing gestation (Figure 6 and Table 2) (p<0.0001).

Table 1:

Detectioon of fetal hyaloid artery at 11–13 + 6 weeks of gestation.

Orbit n FHA
Band Blood flow VHP PVC
Left Right
Bilateral 12 0 12 12 0 1
Unilateral 19 1 10 9 3 7
  1. FHA, fetal hyaloid artery; VHP, vasa hyaloidea propria; PVC, posterior vascular capsule.

Figure 5: 
Blood flow of the string fetal hyaloid artery (HA) detected in one orbit at 13 weeks and 5 days.
Figure 5:

Blood flow of the string fetal hyaloid artery (HA) detected in one orbit at 13 weeks and 5 days.

Figure 6: 
The incidence of curved- and straight-type fetal hyaloid arteries at 11–13 + 6 weeks of gestation.
Figure 6:

The incidence of curved- and straight-type fetal hyaloid arteries at 11–13 + 6 weeks of gestation.

Table 2:

Starting point angle of fetal hyaloid artery at 11–13 + 6 weeks of gestation.

GA,

weeks
n Starting point angle of hyaloid artery
Curved Straighta
11 7 7 0
12 19 16 3
13 17 2 15
  1. ap<0.0001. GA, gestational age.

In a fetus with Trisomy 21 at 12 weeks and 1 day of gestation, straight-type FHA was noted in the left orbit, whereas FHA could not be identified in the right orbit (Figure 7).

Figure 7: 
Fetal hyaloid artery (HA) in a fetus with trisomy 21 at 12 weeks and 1 day of gestation. Straight-type fetal HA can be noted in the left orbit, whereas HA cannot be identified in the right orbit. L, lens; OA, ophthalmic artery.
Figure 7:

Fetal hyaloid artery (HA) in a fetus with trisomy 21 at 12 weeks and 1 day of gestation. Straight-type fetal HA can be noted in the left orbit, whereas HA cannot be identified in the right orbit. L, lens; OA, ophthalmic artery.

Discussion

Using conventional power Doppler, FHA blood flow could be identified between 14 and 16 weeks of gestation [2]. However, to our knowledge, the current study is the first report on the detection of FHA in the first trimester of pregnancy, and FHA blood flow could be depicted using SlowflowHD in all 43 orbits studied at 11–13 + 6 weeks of gestation. Moreover, the vasa hyaloidea propria was identified in 3 out of 43 orbits (7 %). The role of the vasa hyaloidea propria is blood supply to the primary vitreous [8]. In our previous investigation using SlowflowHD, the vasa hyaloidea propria was noted in only 4.9 % at 18–21 + 6 weeks of gestation, whereas these vessels could not be recognized at 28–31 + 6 weeks [3]. In this study, blood flow on the band of FHA could be detected. The change from the blood flow type of FHA to the band type was noted in 13.6 % of cases studied with advancing gestation [3]. This case suggests the simultaneous transition from the blood flow type of FHA to band type in the same vessel in the first trimester. Moreover, in this study, we identified two types of FHA: Curved- and Straight-types. The incidence of Curved-type FHA decreased, and Straight-type FHA increased during this short first-trimester period. The lens diameter/orbital diameter decreased with advancing gestation [9]. Morphological change in the fetal orbit during pregnancy may explain the change in FHA running. SlowflowHD should provide unique and novel information on human eye development in the first trimester of pregnancy.

Birnholz and Farrell [10] suggested that delayed regression of FHA occurs in trisomy 21. However, the number of trisomy 21 cases was very small in their study. In the present study, FHA could not be detected in the unilateral orbit in the case with trisomy 21 in the first trimester of pregnancy. Many children with Down syndrome had hyperopia (69.1 %) and astigmatism (58.5 %) [11]. Our findings may be related to ocular disorders in children with trisomy 21. However, the data and their interpretation should be taken with some degree of caution because of the small number of Down syndrome cases studied. Further studies involving larger sample sizes of Down syndrome cases are mandatory to confirm FHA regression during pregnancy in fetuses with trisomy 21.

With respect to the safety of the use of SlowflowHD during pregnancy, TI values of the SlowflowHD modality were within recommended values set by the World Federation for Ultrasound in Medicine and Biology, American Institute of Ultrasound in Medicine, and British Medical Ultrasound Society [12]. In the present study, TI and MI values during SlowflowHD examinations were≤1. The SlowflowHD examination time (2 min) in our study was very short, and scanning was performed in accordance with the ALARA principle (examining with exposure As Low As Reasonably Achievable) 13], [14], [15. Moreover, a fetal eye may be more effectively cooled due to the surrounding amniotic fluid environment [16].


Corresponding author: Toshiyuki Hata, MD, PhD, Special Adviser, Professor Emeritus, Department of Obstetrics and Gynecology, Miyake Clinic, 369-8 Ofuku, Minami-ku, Okayama 701-0204, Japan; and Department of Perinatology and Gynecology, Kagawa University Graduate School of Medicine, 1750-1 Ikenobe, Miki, Kagawa 761-0793, Japan, E-mail:

  1. Research ethics: The local Institutional Review Board deemed the study exempt from review.

  2. Informed consent: Informed consent was obtained from all individuals included in this study

  3. Author contributions: TH: conception of the work, study design and coordination, supervision of the study, acquisition and validation of the data, analyze and interpretation of the data, writing of the manuscript, and drafting the work. AK: study design and coordination, and acquisition and validation of the data, analyze and interpretation of the data, collecting outcomes, and drafting the work. RT: study design and coordination, and acquisition and validation of the data, analyze and interpretation of the data, and drafting the work. YM: interpretation of data for the work, statistical analysis of the data, and revising the work. TM: study design and coordination, interpretation of data for the work, supervision of the study, and revising the work. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: Not applicable.

References

1. Bronshtein, M, Zimmer, E, Gershoni-Baruch, R, Yoffe, N, Meyer, H, Blumenfeld, Z. First- and second-trimester diagnosis of fetal ocular defects and associated anomalies: report of eight cases. Obstet Gynecol 1991;77:443–9.Search in Google Scholar

2. Achiron, R, Kreiser, D, Achiron, A. Axial growth of the fetal ee and evaluation of the hyaloid artery: in utero ultrasonographic study. Prenat Diagn 2000;20:894–9. https://doi.org/10.1002/1097-0223(200011)20:11<894::aid-pd949>3.0.co;2-j.Search in Google Scholar

3. Hata, T, Koyanagi, A, Yamanishi, T, Bouno, S, Takayoshi, R, Miyake, T. Natural course of fetal hyaloid artery: SlowflowHD longitudinal study. J Ultrasound Med 2022;41:2259–67. https://doi.org/10.1002/jum.15911.Search in Google Scholar

4. Hata, T, Mori, N, Yamamoto, K, Hanaoka, U, Miyake, T, Kanenishi, K. SlowflowHD for detection of small fetal peripheral vasculature. Donald Sch J Ultrasound Obstet Gynecol 2019;13:155–8. https://doi.org/10.5005/jp-journals-10009-1603.Search in Google Scholar

5. Hata, T, Koyanagi, A, Yamanishi, T, Bouno, S, Takayoshi, R, Miyake, T. Fetal abdominal blood vessels and organ microvasculature detected by SlowflowHD. Ultrasound Obstet Gynecol 2020;56:955–7. https://doi.org/10.1002/uog.22043.Search in Google Scholar

6. Okai, T. Standard values of ultrasonic measurements in Japanese fetuses. J Med Ultrason 2003;30:J415–40.Search in Google Scholar

7. Landis, JR, Koch, GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977;33:363–74. https://doi.org/10.2307/2529786.Search in Google Scholar

8. Moore, KL, Persaud, TVN. 18. The eye and ear. In: Moore, KL, Persaud, TVN, Torchia, MG, editors. The developing human. Clinically oriented embryology, 8th ed. Philadelphia, PA: Saunders Elsevier; 2008:419–38 pp.Search in Google Scholar

9. Goldstein, I, Tamir, A, Zimmer, EZ, Itskovitz-Eldor, J. Growth of the fetal orbit and lens in normal pregnancies. Ultrasound Obstet Gynecol 1998;12:175–9. https://doi.org/10.1046/j.1469-0705.1998.12030175.x.Search in Google Scholar

10. Birnholz, JC, Farrell, EE. Fetal hyaloid artery: timing of regression with US. Radiology 1988;166:781–3. https://doi.org/10.1148/radiology.166.3.3277246.Search in Google Scholar

11. Tomita, K, Tsurui, H, Otsuka, S, Kato, K, Kimua, A, Shiraishi, Y, et al.. Ocular findings in 304 children with Down syndrome. Nippon Ganka Gakkai Zasshi 2013;117:749–60.Search in Google Scholar

12. Drukker, L, Droste, R, Ioannou, C, Impey, L, Noble, JA, Papageorghiou, AT. Function and safety of SlowflowHD ultrasound doppler in obstetrics. Ultrasound Med Biol 2022;48:1157–62. https://doi.org/10.1016/j.ultrasmedbio.2022.02.012.Search in Google Scholar

13. AIUM. Medical Ultrasound Safety. Laurel, MD: American Institute of Ultrasound in Medicine; 1994.Search in Google Scholar

14. Kremkau, FW. Contemporary ultrasound technology. Ultrasound Obstet Gynecol 1995;6:233–6. https://doi.org/10.1046/j.1469-0705.1995.06040233.x.Search in Google Scholar

15. Abramowicz, JS, Adhikari, S, Dickman, E, Estroff, JA, Harris, GR, Nomura, J, et al.. Ocular ultrasound. Review of bioeffects and safety, including fetal and point of care perspective. J Ultrasound Med 2022;41:1609–22. https://doi.org/10.1002/jum.15864.Search in Google Scholar

16. Safety Group of the British Medical Ultrasound Society. Guidelines for the safe use of diagnostic ultrasound equipment. Ultrasound 2010;18:52–9. https://doi.org/10.1258/ult.2010.100003.Search in Google Scholar

Received: 2024-06-09
Accepted: 2024-08-25
Published Online: 2024-10-09

© 2024 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Case Reports – Obstetrics
  2. Peripartum COVID-19 & hemophagocytic lymphohistiocytosis: a case report
  3. An unusual case of twin anemia polycythemia sequence complicated by premature ductus arteriosus constriction of the recipient twin
  4. Acute fatty liver of pregnancy with transient resolution preceding postpartum liver failure requiring liver transplant
  5. Fetal hyaloid artery in first trimester of pregnancy: slowflowHD study
  6. Prenatal diagnosis of fetal neurogenic megacystis associated with lethal congenital contractural syndrome 2
  7. Novel homozygous mutation in the human RAX homeobox gene in a patient with bilateral anophthalmia and severe endocrine dysfunction – a case report and literature review
  8. Umbilical artery thrombosis diagnosed by fetal ultrasound
  9. Complicated diverticulitis with colovesical fistula and bladder abscess formation in pregnancy: a case report
  10. Massive fetal goiter treated by intra-amniotic injection of levothyroxine: a case report
  11. Aplasia cutis congenita as a complication of early interstitial laser embryo reduction in a case of monochorionic triamniotic triplet pregnancy ‒ a case report
  12. Fetal bladder rupture after high-dose maternal opioid treatment: a case report
  13. Case report of congenital myotonic dystrophy with multiple prenatal sonographic findings
  14. Case study: autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks’ gestation
  15. Radiofrequency thermal ablation of giant placental chorioangioma complicated with fetal hydrops: a case report and successful outcome
  16. Acquired factor VIII deficiency in a nulliparous patient undergoing induction of labor
  17. Case Reports – Newborn
  18. Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring
  19. Persistent pulmonary hypertension of the newborn infant (PPHN) due to premature closure of the ductus arteriosus (DA)
  20. Aromatase deficiency due to novel CYP19A1 mutation: a rare cause of maternal and fetal virilization
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/crpm-2024-0025/html
Scroll to top button